[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612731":3},{"organization":4,"outcomesModule":7,"designInfo":23,"detailedDescription":26,"studyPopulation":27,"armGroups":28,"interventions":38,"overallOfficials":43,"centralContacts":48,"locations":56,"responsibleParty":71,"collaborators":11,"id":73,"slug":11,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":11,"enrollmentInfo":82,"targetDuration":11,"studyType":85,"phases":11,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":97,"whyStopped":11,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Taipei Medical University Shuang Ho Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Change in fall-risk index (Kinetikos Health App Sit-to-Stand)",null,"From baseline to 3 months",[14,17,20],{"measure":15,"description":16,"timeFrame":12},"UPDRS","Change in MDS-UPDRS axial score; Change in MDS-UPDRS Part II",{"measure":18,"description":19,"timeFrame":12},"Fall events","Fall events during 3 months",{"measure":21,"description":22,"timeFrame":12},"LEDD","Change in LEDD",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":24,"timePerspective":25,"maskingInfo":11},"COHORT","PROSPECTIVE","Falls are common and disabling in PD. Dopaminergic medication effects on fall risk remain inconclusive. This study validates the Kinetikos Health App for objective fall risk assessment before and after medication adjustment.","Patients from outpatient neurology clinic, Shuang Ho Hospital, Taipei Medical University",[29,34],{"label":30,"type":11,"description":31,"interventionNames":32},"Opicapone group","PD patients undergo dopaminergic medication adjustments",[33],"Other: No Intervention: Observational Cohort",{"label":35,"type":11,"description":36,"interventionNames":37},"Safinamide group","PD patients undergoing dopaminergic medication adjustments",[33],[39],{"type":6,"name":40,"description":41,"armGroupLabels":42,"otherNames":11},"No Intervention: Observational Cohort","No intervention.",[30,35],[44],{"name":45,"affiliation":46,"role":47},"Chen-Chih Chung, MD","Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan","PRINCIPAL_INVESTIGATOR",[49,53],{"name":45,"role":50,"phone":51,"phoneExt":11,"email":52},"CONTACT","+886-2-22490088","10670@s.tmu.edu.tw",{"name":54,"role":50,"phone":11,"phoneExt":11,"email":55},"Chien Tai Hong, MD, PhD","15004@s.tmu.edu.tw",[57],{"facility":58,"status":11,"city":59,"state":11,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"Shuang Ho Hospital, Taipei Medical University","New Taipei City","235","Taiwan","TW",{"type":64,"coordinates":65},"Point",[66,67],121.45703,25.06199,{"lat":67,"lon":66},[70],{"name":45,"role":50,"phone":51,"phoneExt":11,"email":52},{"type":72,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100612731",false,"NCT07257393","Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health","Validation of a Mobile Health Application for Fall Risk Assessment in Parkinson's Disease: A Comparative Study Before and After Dopaminergic Medication Adjustment","PD_FALLRISK","Inclusion Criteria:\n\n1. Age ≥20;\n2. PD diagnosis (MDS criteria);\n3. On levodopa monotherapy with motor fluctuations;\n4. Planned to start opicapone or safinamide;\n5. Consent provided.\n\nExclusion Criteria:\n\n1. Atypical\u002Fsecondary parkinsonism;\n2. Moderate-severe dementia;\n3. DBS\u002FMRgFUS\u002Fneurosurgery within 6 months;\n4. Severe comorbidities limiting test","ALL","20 Years",{"count":83,"type":84},100,"ESTIMATED","OBSERVATIONAL","This is a single-center, prospective observational study aiming to validate the Kinetikos Health App for fall risk assessment in PD patients undergoing dopaminergic medication adjustments.",[88],"Idiopathic Parkinsonism",[90,91,92,93,94,95,96],"Parkinson's disease","Fall risk","Motor fluctuation","Dopaminergic medication","Mobile health","Sit-to-Stand","Kinetikos Health App","NOT_YET_RECRUITING","2025-12-03",{"date":100,"type":101},"2025-12-04","ACTUAL",{"date":103,"type":84},"2025-12-01",{"date":105,"type":84},"2026-06-30",{"name":5,"class":6},1]